Cases started on MDR-TB treatment in India
India: Cases started on MDR-TB treatment was 51,765 in 2024. ◆ Volatile
Cases started on MDR-TB treatment in India, 2008–2024
Source: World Health Organization, Global Health Observatory.
Analysis
In 2024, cases started on mdr-tb treatment in India stood at 51,765.
Compared with earlier readings it is down 11.9% on the previous year and up 115.0% over ten years.
Over the whole period, cases started on mdr-tb treatment in India peaked at 60,858 in 2019 and was at its lowest, 190, in 2008.
That places India 1st out of 193 countries with data for 2024, putting it in the top 10%.
The series is highly variable year to year, so single readings are best treated with caution.
Cases started on MDR-TB treatment in India, year by year
| Year | Value | Change |
|---|---|---|
| 2008 | 190 | — |
| 2009 | 1,136 | +497.9% |
| 2010 | 2,182 | +92.1% |
| 2011 | 3,378 | +54.8% |
| 2012 | 14,117 | +317.9% |
| 2013 | 21,093 | +49.4% |
| 2014 | 24,073 | +14.1% |
| 2015 | 26,966 | +12.0% |
| 2016 | 32,914 | +22.1% |
| 2017 | 35,950 | +9.2% |
| 2018 | 47,284 | +31.5% |
| 2019 | 60,858 | +28.7% |
| 2020 | 42,505 | -30.2% |
| 2021 | 53,037 | +24.8% |
| 2022 | 60,421 | +13.9% |
| 2023 | 58,780 | -2.7% |
| 2024 | 51,765 | -11.9% |
India compared with similar countries
- India's 51,765 is above the median for lower middle income countries, which is 120, 431.4× the median. (47 countries reporting)
- India's 51,765 is above the median for South Asia, which is 352, 147.1× the median. (6 countries reporting)
Biggest year-on-year movements
Years where Cases started on MDR-TB treatment in India changed far more than this series normally does. A large move can be a real event or a change in how the figure was measured — the source note below says who published it.
| Year | Change | From | To |
|---|---|---|---|
| 2009 | +497.9% | 190 | 1,136 |
| 2012 | +317.9% | 3,378 | 14,117 |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 663 | 190 | 1,136 | 2 |
| 2010s | 26,882 | 2,182 | 60,858 | 10 |
| 2020s | 53,302 | 42,505 | 60,421 | 5 |
Countries ranked near India
More health data for India
- Un projection of annual infant deaths, annual growth rate -2.12 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.4372 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,332 deaths per 1,000 people (2090)
- Number of infants who die before age 1 44,822 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 38 (2025)
- Population ages 00-04, female, annual growth rate -0.3809 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0372 units per person (2025)
- Population ages 00-04, male, annual growth rate -0.5922 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is cases started on mdr-tb treatment in India?
- Cases started on mdr-tb treatment in India was 51,765 in 2024, according to World Health Organization, Global Health Observatory.
- What is the highest cases started on mdr-tb treatment recorded in India?
- The highest recorded value was 60,858 in 2019.
- What is the lowest cases started on mdr-tb treatment recorded in India?
- The lowest recorded value was 190 in 2008.
- How does India rank for cases started on mdr-tb treatment?
- India ranks 1st out of 193 countries with data for 2024.
- Is cases started on mdr-tb treatment rising or falling in India?
- Over the last ten years it is up 115.0%. The long-run trend across the full record is volatile.
- Where does this India data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Cases started on MDR-TB treatment. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 17 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).